Featured Research

from universities, journals, and other organizations

Lack Of A Protein In Lung Tumors May Increase Risk Of Death

Date:
March 28, 2007
Source:
Ohio State University
Summary:
A study of human lung tumors indicates that lung cancer patients who lack a particular protein may do more poorly than those with normal levels of that same protein. If the findings are verified in a clinical trial, the absence of the protein might be used to identify lung cancer patients who need more aggressive therapy after surgery.

A study of human lung tumors indicates that lung cancer patients who lack a particular protein may do more poorly than those with normal levels of that same protein.

If the findings are verified in a clinical trial, the absence of the protein might be used to identify lung cancer patients who need more aggressive therapy after surgery.

The protein is the product of a gene called Olig1, which previously has not been linked with lung cancer, and it is located in a chromosome region that is often lost in the tumor cells of many lung-cancer patients.

The research examined tumors from people with non-small cell lung cancer (NSCLC), the most common form of lung cancer. It sought to identify genes that are turned off, or silenced, by a process called aberrant DNA methylation.

The study wanted to learn if the pattern of silenced genes could distinguish between two subtypes of NSCLC, adenocarcinoma and squamous cell carcinoma.

The research identified 47 genes that together can differentiate between the two lung cancer subtypes. It also found that the silencing of the Olig1 gene – which results in the absence or low levels of its protein product – was linked to poor survival in NSCLC patients.

The study, led by researchers at the Ohio State University Comprehensive Cancer Center, is published in the March 27 issue of PLoS Medicine.

“We found that when the Olig1 protein is down-regulated or absent, the risk of death is significantly higher compared with patients who have normal levels of the protein,” says first-author Romulo M. Brena, a graduate research associate in molecular genetics and in molecular virology, immunology and medical genetics.

“Even low levels of the protein were associated with better survival,” he says.

The findings might have important clinical significance, says coauthor Gregory Otterson, associate professor of internal medicine and a medical oncologist who specializes in lung cancer treatment.

“This study identified a novel gene that had no known role in lung cancer development and that is silenced in a large number of patients,” says Otterson, also a researcher with the Ohio State University Comprehensive Cancer Center . “The absence of the protein may have important prognostic implications.”

Lung cancer is the leading cause of cancer illness and death worldwide. Every year, an estimated 1.2 million people are diagnosed with the malignancy, and 1.1 million others die from the disease. More than 85 percent of these cases are NSCLC.

Presently, a lung-cancer patient's prognosis is based on how far the disease has progressed, which is determined by staging the disease.

“There is a high correlation between survival and a patient's stage,” Brena says. “But there is also wide variation in overall survival among patients who are in the same stage. Some live for only a short time, others for a longer time.

“We don't know why that is, but it is probably related to the molecular and genetic characteristics of the tumor,” he says. “The presence or absence of Olig1 may be one of those characteristics.”

An analysis of patient survival data indicated that patients with little or no Olig1 in their tumor cells had about a 15 percent decrease in survival.

The researchers are now trying to learn the role of the Olig1 gene and protein in lung cells and how their loss may contribute to cancer development.

Funding from the National Lung Cancer Partnership (formerly Women Against Lung Cancer Foundation), the National Cancer Institute and the V Foundation supported this research.


Story Source:

The above story is based on materials provided by Ohio State University. Note: Materials may be edited for content and length.


Cite This Page:

Ohio State University. "Lack Of A Protein In Lung Tumors May Increase Risk Of Death." ScienceDaily. ScienceDaily, 28 March 2007. <www.sciencedaily.com/releases/2007/03/070327094659.htm>.
Ohio State University. (2007, March 28). Lack Of A Protein In Lung Tumors May Increase Risk Of Death. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2007/03/070327094659.htm
Ohio State University. "Lack Of A Protein In Lung Tumors May Increase Risk Of Death." ScienceDaily. www.sciencedaily.com/releases/2007/03/070327094659.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
CDC Calls for New Ebola Safety Guidelines

CDC Calls for New Ebola Safety Guidelines

AP (Oct. 20, 2014) Centers for Disease Control and Prevention Director Dr. Tom Frieden laid out new guidelines for health care workers when dealing with the deadly Ebola virus including new precautions when taking off personal protective equipment. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins